ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,258,000 | -27.9% | 938,900 | -13.0% | 0.90% | -31.2% |
| Q3 2014 | $4,520,000 | -11.1% | 1,078,600 | +24.3% | 1.31% | -22.3% |
| Q2 2014 | $5,085,000 | -48.5% | 867,700 | -44.7% | 1.68% | -48.8% |
| Q1 2014 | $9,877,000 | -14.8% | 1,567,700 | -20.9% | 3.29% | -32.1% |
| Q4 2013 | $11,591,000 | +71.6% | 1,981,400 | +54.6% | 4.85% | +43.9% |
| Q3 2013 | $6,753,000 | -31.6% | 1,281,400 | 0.0% | 3.37% | -20.0% |
| Q2 2013 | $9,867,000 | – | 1,281,400 | – | 4.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |